Table 1.

IL-10 expression between the two groups at pathological level.

Group	Metastasis, n (%)	Non-metastasis, n (%)	P
High expression	11 (78.6%)	13 (40.6%)
Low expression	3 (21.4%)	19 (59.4%)
total	14 (100.0)	32 (100.0)	0.018

In the metastatic CRC group, 11 cases exhibited high expression of IL-10, while 3 cases showed low expression. Conversely, in the non-metastatic CRC group, 13 cases displayed high IL-10 expression, whereas 19 cases demonstrated low expression. The disparity between the two groups was statistically significant (P = 0.018).

Significant values are in [bold].